Immunovant (IMVT) Current Taxes (2019)

Immunovant's (IMVT) quarterly Current Taxes came in at $106000.0 in Q4 2019, up 236.4% on a QoQ basis from $31510.0 in Q3 2019.

Analysis

Immunovant (IMVT) Current Taxes (2019) Analysis & Trends

Immunovant (IMVT) has 1 years of Current Taxes data on file, last reported at $106000.0 in Q4 2019.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	138.87 Bn	131.01 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.57 Bn	77.57 Bn	3.93 Bn	-
3	Argenx Se	63.51 Bn	58.32 Bn	1.37 Bn	49.00 Mn
4	Moderna	58.19 Bn	53.05 Bn	52.00 Mn	-
5	Revolution Medicines	44.07 Bn	44.07 Bn	-	-
6	BeOne Medicines	39.99 Bn	34.89 Bn	1.53 Bn	76.32 Mn
7	Alnylam Pharmaceuticals	35.38 Bn	32.07 Bn	992.69 Mn	-
8	Royalty Pharma	28.42 Bn	27.58 Bn	-	-
9	Insmed	27.41 Bn	26.25 Bn	358.27 Mn	-
10	Immunovant	8.14 Bn	8.14 Bn	-	-

Historic Data

Download Data